Mathis A, Weber R, Kuster H, Speich R
Institute of Parasitology, University of Zürich, Switzerland.
J Clin Microbiol. 1997 Jul;35(7):1691-5. doi: 10.1128/jcm.35.7.1691-1695.1997.
Early diagnosis of Pneumocystis carinii pneumonia, a life-threatening complication in immunosuppressed patients, may lower morbidity and mortality. We have developed a one-tube nested PCR assay for the detection of P. carinii in respiratory specimens. Four primers were selected from the sequence of the small-subunit rRNA gene of P. carinii to amplify a 265-bp fragment, and their specificities for P. carinii were confirmed by both theoretical evaluations (by computer-assisted comparison with the sequences in GenBank) and empirical evaluations (with DNA from medically important fungi and diagnostic samples). The assay was optimized for routine diagnostic use. Processing of the clinical samples is rapid and simple (digestion with proteinase K directly in PCR buffer at room temperature in the presence of 10% Chelex 100 and no further purification steps). Bovine serum albumin (1 mg/ml) and glycerol (10%) in the amplification buffer reduced the number of samples inhibitory to the PCR, as assessed by control reactions containing a size-modified target. A total of 749 clinical specimens (312 bronchoalveolar lavage, 403 sputum or induced sputum, and 34 other specimens) from 507 patients (295 human immunodeficiency virus [HIV]-infected and 164 non-HIV-infected patients and 48 patients whose HIV status was unknown) were tested by PCR, and the results were compared with those of an indirect immunofluorescence assay (IFA). Concordant results were obtained for 732 samples (646 negative and 86 positive). There were 17 discrepant results: 12 were PCR positive and IFA negative, and 5 were PCR negative and IFA positive. After resolution of the discrepant results by review of the patients' clinical data, the sensitivity and specificity were 94.8 and 99.1%, respectively, for PCR and 93.8 and 100%, respectively, for IFA. In conclusion, the short procedure time and the technical ease of this PCR assay render it suitable for implementation in routine diagnostic laboratories.
卡氏肺孢子虫肺炎是免疫抑制患者的一种危及生命的并发症,早期诊断可降低发病率和死亡率。我们开发了一种单管巢式聚合酶链反应(PCR)检测法,用于检测呼吸道标本中的卡氏肺孢子虫。从卡氏肺孢子虫小亚基核糖体RNA基因序列中选择了4条引物,以扩增一个265bp的片段,并通过理论评估(通过计算机辅助与GenBank中的序列进行比较)和实证评估(使用医学上重要真菌的DNA和诊断样本)来确认它们对卡氏肺孢子虫的特异性。该检测法已针对常规诊断用途进行了优化。临床样本的处理快速且简单(在室温下于PCR缓冲液中直接用蛋白酶K消化,同时存在10%的Chelex 100,无需进一步纯化步骤)。通过含有大小修饰靶标的对照反应评估,扩增缓冲液中的牛血清白蛋白(1mg/ml)和甘油(10%)减少了抑制PCR的样本数量。对507例患者(295例感染人类免疫缺陷病毒[HIV]、164例未感染HIV以及48例HIV感染状况未知)的749份临床标本(312份支气管肺泡灌洗标本、403份痰液或诱导痰液标本以及34份其他标本)进行了PCR检测,并将结果与间接免疫荧光法(IFA)的结果进行比较。732份样本(646份阴性和86份阳性)的结果一致。有17份结果不一致:12份PCR阳性而IFA阴性,5份PCR阴性而IFA阳性。通过复查患者的临床数据解决不一致结果后,PCR的敏感性和特异性分别为94.8%和99.1%,IFA的敏感性和特异性分别为93.8%和100%。总之,该PCR检测法操作时间短且技术简便,适合在常规诊断实验室中应用。